Blood and Bone Marrow Cancers

Johns Hopkins cancer research and treatment for blood cancers, including advanced therapies and dedicated experts, is available at Sibley Memorial Hospital's Kimmel Cancer Center in the D.C. region.This includes Bone Marrow Transplant (BMT) services, with Johns Hopkins physicians—appointed by the Johns Hopkins University School of Medicine—providing a full range of the most advanced treatments and conducting ongoing clinical trials.

Learn More About Blood and Bone Marrow Cancers

An Academic Center of Excellence

As a Johns Hopkins academic center, Sibley offers state-of-the-art treatments not available at community hospitals. Including IPOP (inpatient/outpatient) a new, carefully adapted approach to stem cell transplants which allows patients to be at home for most of their treatment, rather than spending months in the hospital. Sibley also offers therapies that attack specific parts of cancer cells, with less toxicity than other treatments. Opening treatment options to patients of all ages. Advanced radiology therapies available at Sibley include proton therapy, which is rarely available even at other large cancer centers.

Our Team

At Johns Hopkins, our physician-scientists lead ground breaking research to find the most effective treatments. At Sibley, a dedicated team of doctors, nurses, pharmacists, and social workers work together to provide expert care for patients with blood and bone marrow cancers. Our highly trained professionals ensure patients receive the latest, most advanced treatments along with compassionate support.

Clinical Trials

Clinical trials give you access to new treatments, such as new chemotherapy drugs or immunotherapy, that may work better for you than standard options. A leader in medical research, Johns Hopkins offers the latest therapies and technologies and may also connect you trials at other organizations. We recommend that you ask your treatment team about clinical trials early on.

  • Lymphoma and Cellular Therapy

    In this Cancer Matters podcast, Dr Bill Nelson speaks with Dr Nina Wagner-Johnston about the treatment of lymphoma and the newly opened Cellular Therapy Program at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington DC.

    Illustration of an old school microphone.
  • Novel Bone Marrow Transplant Can Cure Sickle Cell Disease

    A bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative for adults with sickle cell disease, according to results of a trial completed at Johns Hopkins and about 20 additional cancer centers nationwide and in London.

    Graphics of Sickle cells Credit: Adobe Stock